Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dementia of Alzheimer's Type”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02322021
What this trial is testing

Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia, Alzheimer Type
Eisai Inc. 70
Large-scale testing (Phase 3)Looking for participantsNCT06647498
What this trial is testing

A Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Who this might be right for
Alzheimers DiseaseDementiaAlzheimers Disease, Familial
Washington University School of Medicine 280
Large-scale testing (Phase 3)Study completedNCT01922258
What this trial is testing

Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Agitation Associated WithAlzheimer's DiseaseAlzheimer's Type+2 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 270
Large-scale testing (Phase 3)Study completedNCT03226522
What this trial is testing

Addressing Dementia Via Agitation-Centered Evaluation

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation,Psychomotor
Axsome Therapeutics, Inc. 366
Testing effectiveness (Phase 2)Study completedNCT02185053
What this trial is testing

A Phase II Study of CPC-201 to Treat Alzheimer's Disease Type Dementia

Who this might be right for
Alzheimer's Disease
Chase Pharmaceuticals Corporation, an affiliate of Allergan plc 41
Large-scale testing (Phase 3)Looking for participantsNCT07066826
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of Huperzine A Controlled-Release Tablets in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer Dementia
Wanbangde Pharmaceutical Group Co., LTD 720
Testing effectiveness (Phase 2)Study completedNCT01148498
What this trial is testing

A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 55
Not applicableStudy completedNCT00880347
What this trial is testing

Blood Gene Expression Signature in Patients Diagnosed With Probable Alzheimer's Disease Compared to Patients Suffering From Other Types of Dementia

Who this might be right for
Alzheimer's DiseaseDementia
Exonhit 550
Not applicableStudy completedNCT04742465
What this trial is testing

ARIADE : Augmented Reality for Improving Autonomy in Dementia

Who this might be right for
Alzheimer or Mild Cognitive Impairment
Rennes University Hospital 19
Not applicableStudy completedNCT01819714
What this trial is testing

Sensory Support Care for Elderly Patients Suffering From Alzheimer'S-type Neurodegenerative Disease

Who this might be right for
Alzheimer Disease
Centre Hospitalier Universitaire de Nīmes 31
Not applicableUnknownNCT04526262
What this trial is testing

Assessment of Initial Efficacy and Safety of High Intensity Focused Ultrasound 'ExAblate 4000 Type 2' for Blood Brain Barrier Disruption in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Yonsei University 6
Testing effectiveness (Phase 2)Study completedNCT00130429
What this trial is testing

Safety and Effect on Memory of PYM50028 in Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Phytopharm 250
Testing effectiveness (Phase 2)Looking for participantsNCT06052254
What this trial is testing

Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Agitation
Teikoku Pharma USA, Inc. 150
Post-approval studies (Phase 4)Study completedNCT00216515
What this trial is testing

The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type

Who this might be right for
Alzheimer Disease
Janssen Korea, Ltd., Korea 102
Not applicableStudy completedNCT02460783
What this trial is testing

Intermittent Calorie Restriction, Insulin Resistance, and Biomarkers of Brain Function

Who this might be right for
Alzheimer's DiseaseObesityDiabetes Mellitus
National Institute on Aging (NIA) 129
Testing effectiveness (Phase 2)Study completedNCT00976118
What this trial is testing

Activity of Masitinib (AB1010) in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
AB Science 34
Testing effectiveness (Phase 2)Study completedNCT03875638
What this trial is testing

Treating Hyperexcitability in AD With Levetiracetam

Who this might be right for
Alzheimer DementiaAlzheimer DiseaseDementia of Alzheimer Type+1 more
Beth Israel Deaconess Medical Center 58
Large-scale testing (Phase 3)Ended earlyNCT00857233
What this trial is testing

Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
H. Lundbeck A/S 297
Large-scale testing (Phase 3)Study completedNCT04947553
What this trial is testing

Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation, Psychomotor
Axsome Therapeutics, Inc. 456
Large-scale testing (Phase 3)Active Not RecruitingNCT06125951
What this trial is testing

Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease

Who this might be right for
Dementia ModerateDementia, MildAlzheimer Disease
Actinogen Medical 247
Next Page